Cannagistics, Inc.

Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.

Cannagistics, Inc. trades as CNGT on OTC. The company is classified in Financial Services / Shell Companies and reports in USD.

The current profile places the business in Shell Companies. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$17.35M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Cannagistics, Inc. can be compared against peers such as Beite Energy Corporation, Clone Algo Technologies Inc., Chun Can Capital Group, Maclos Capital Inc., Lux Amber, Corp., Nemo Motors Corp.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $29,634, beta of 3.28, and return on equity of +307.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CNGT currently shows total debt of $2.85M and beta of 3.28. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: REVOKED (2025-03-10 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.cannagistics.io

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.